DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
Clinical trial NCT03356080 · UNKNOWN
Trial details
- NCT number
- NCT03356080
- Sponsor
- Shanghai Tong Ren Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2019-07-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.